PP_1170x120_10-25-21

silodosin

Aurobindo gets FDA approval for silodosin capsules

Aurobindo gets FDA approval for silodosin capsules

EAST WINDSOR, N.J. – Aurobindo Pharma Ltd. has received final approval from the Food and Drug Administration for its Abbreviated New Drug Application for silodosin capsules, 4 mg and 8 mg. Aurobindo’s silodosin capsules are an AB-rated generic equivalent to the reference listed drug, Allergan Sales, LLC’s Rapaflo. Silodosin, an alpha-1 adrenergic receptor antagonist, is